These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 8304273)

  • 21. How to best manage time interaction with patients? Community pharmacist workload and service provision analysis.
    Gregório J; Cavaco AM; Lapão LV
    Res Social Adm Pharm; 2017; 13(1):133-147. PubMed ID: 26997136
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interpersonal perception: a theory and method for studying pharmacists' and patients' views of pharmaceutical care.
    Assa M; Shepherd EF
    J Am Pharm Assoc (Wash); 2000; 40(1):71-81; quiz 123-5. PubMed ID: 10665252
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship between attitudes toward mental illness and provision of pharmacy services.
    Rickles NM; Dube GL; McCarter A; Olshan JS
    J Am Pharm Assoc (2003); 2010; 50(6):704-13. PubMed ID: 21071314
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Community pharmacists' attitudes toward providing care and services to patients with severe and persistent mental illness.
    Watkins A; McKee J; Hughes C; Pfeiffenberger T
    J Am Pharm Assoc (2003); 2017; 57(3S):S217-S224.e2. PubMed ID: 28408170
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Community pharmacist-led clinical services: physician's understanding, perceptions and readiness to collaborate in a Midwestern state in the United States.
    Gordon C; Unni E; Montuoro J; Ogborn DB
    Int J Pharm Pract; 2018 Oct; 26(5):407-413. PubMed ID: 29218803
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A qualitative study exploring perceptions and attitudes of community pharmacists about extended pharmacy services in Lahore, Pakistan.
    Hashmi FK; Hassali MA; Khalid A; Saleem F; Aljadhey H; Babar ZUD; Bashaar M
    BMC Health Serv Res; 2017 Jul; 17(1):500. PubMed ID: 28724411
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessing the effects of pharmacists' perceived organizational support, organizational commitment and turnover intention on provision of medication information at community pharmacies in Lithuania: a structural equation modeling approach.
    Urbonas G; Kubilienė L; Kubilius R; Urbonienė A
    BMC Health Serv Res; 2015 Mar; 15():82. PubMed ID: 25885819
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of community pharmacy-based services for type-2 diabetes in an Indonesian setting: pharmacist survey.
    Wibowo Y; Parsons R; Sunderland B; Hughes J
    Int J Clin Pharm; 2015 Oct; 37(5):873-82. PubMed ID: 25986291
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmaceutical care in a community-based practice setting in Jordan: where are we now with our attitudes and perceived barriers?
    Aburuz S; Al-Ghazawi M; Snyder A
    Int J Pharm Pract; 2012 Apr; 20(2):71-9. PubMed ID: 22416931
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Community pharmacists' prescription intervention practices--exploring variations in practice in Norwegian pharmacies.
    Mandt I; Horn AM; Ekedahl A; Granas AG
    Res Social Adm Pharm; 2010 Mar; 6(1):6-17. PubMed ID: 20188324
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacist and physician perspectives on diabetes service delivery within community pharmacies in Indonesia: a qualitative study.
    Wibowo Y; Sunderland B; Hughes J
    Int J Pharm Pract; 2016 May; 24(3):180-8. PubMed ID: 26670327
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessing the relationship between pharmacists' job satisfaction and over-the-counter counselling at community pharmacies.
    Urbonas G; Kubilienė L
    Int J Clin Pharm; 2016 Apr; 38(2):252-60. PubMed ID: 26666908
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Workload in community pharmacies in the UK and its impact on patient safety and pharmacists' well-being: a review of the evidence.
    Hassell K; Seston EM; Schafheutle EI; Wagner A; Eden M
    Health Soc Care Community; 2011 Nov; 19(6):561-75. PubMed ID: 21623986
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Facilitators for practice change in Spanish community pharmacy.
    Gastelurrutia MA; Benrimoj SI; Castrillon CC; de Amezua MJ; Fernandez-Llimos F; Faus MJ
    Pharm World Sci; 2009 Feb; 31(1):32-9. PubMed ID: 18998235
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmaceutical care in chain pharmacies: beliefs and attitudes of pharmacists and patients.
    Amsler MR; Murray MD; Tierney WM; Brewer N; Harris LE; Marrero DG; Weinberger M
    J Am Pharm Assoc (Wash); 2001; 41(6):850-5. PubMed ID: 11765110
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of community pharmacy automation on workflow, workload, and patient interaction.
    Angelo LB; Christensen DB; Ferreri SP
    J Am Pharm Assoc (2003); 2005; 45(2):138-44. PubMed ID: 15868755
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmaceutical care for people with depression: Belgian pharmacists' attitudes and perceived barriers.
    Liekens S; Smits T; Laekeman G; Foulon V
    Int J Clin Pharm; 2012 Jun; 34(3):452-9. PubMed ID: 22477208
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diabetes care in Qatar: a survey of pharmacists' activities, attitudes and knowledge.
    El Hajj MS; Abu Yousef SE; Basri MA
    Int J Clin Pharm; 2018 Feb; 40(1):84-93. PubMed ID: 29147964
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Barriers and facilitators to dispensing of intranasal naloxone by pharmacists.
    Bakhireva LN; Bautista A; Cano S; Shrestha S; Bachyrycz AM; Cruz TH
    Subst Abus; 2018; 39(3):331-341. PubMed ID: 29043922
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacists' attitudes toward and practices with adolescents.
    Conard LA; Fortenberry JD; Blythe MJ; Orr DP
    Arch Pediatr Adolesc Med; 2003 Apr; 157(4):361-5. PubMed ID: 12695232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.